HNHacker News
TopNewBestAskShowJobs

criticaltinker

1,200 karma · joined July 23, 2021

submissionscomments
criticaltinker··on Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity [pdf]
Yeah good points all around. Just wanted to mention that even in the high quality phase 3 vaccine trials they found evidence that immunity acquired from previous infection was effective at preventing subsequent symptomatic illness. Obviously that wasn't the primary goal so it was hardly even mentioned in the published papers, but you can see it in the raw data. For example, from the Moderna phase 3 RCT [1] see table S17 on page 42 [2].

Out of the people with natural immunity from previous infection: only 1 out of 337 unvaccinated people were reinfected, and 0 out of 343 vaccinated people were reinfected.

Admittedly they didn't have a large number of participants in this cohort, so their statistical power was limited in this respect, perhaps contributing to their rational for not mentioning it as a primary finding.

[1] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (Moderna) https://www.nejm.org/doi/full/10.1056/nejmoa2035389

[2] Table S17. Vaccine Efficacy by SARS-COV-2 Status, Modified Intent-to-Treat https://www.nejm.org/doi/suppl/10.1056/NEJMoa2035389/suppl_f...

criticaltinker··on Natural and Vaccine Immunity Against the SARS-CoV-2 Endemic Virus
> our position is the vaccines do induce a strong immune response against their target. They save lives, and this is clear in the lower death rate associated with the Delta variant wave.

> This makes vaccination very important in high-risk groups, such as elderly, and those with obesity, diabetes or cardiovascular disease.

> The number of adverse cardiac events in young people, especially males, is high. The vaccine seems, in some cases, to be causing heart issues in some men under 29 years old (22-27 myocarditis events per million doses).

> Due to the high COVID-19 survival rate in the under 29-year-old age cohort, it is reasonable to question the risk vs benefit of vaccination.

> vaccines carry risks, and a core concept in medicine is to do no more intervention than is necessary. Without evidence of failed natural immunity after infection, the risks of vaccination may outweigh the benefits.

The OP article was well-written and provided an extremely balanced and accurate interpretation of current scientific consensus. Because the infection fatality rate is extremely low for young healthy adults, and the protection afforded by immunity acquired through previous infection is so effective, the risk-reward calculus changes. I see you've rounded down to "nearly 0 risk", but the fact is the risk is non-zero - that's why the CDC is actively investigating & monitoring the unexpectedly high number of myocarditis cases in in young males, particularly children.

> The only logical response to the data he presents is get vaccinated

As of now the scientific literature has demonstrated that the impact of further vaccination on top of naturally acquired immunity may be marginal and potentially insignificant, especially for young healthy adults. This is relevant to public health policy and vaccination strategy, because we have a limited supply of vaccine doses. It is "logical" to prioritize those doses to people who are immunologically naive, or vulnerable due to age and comorbidities.

criticaltinker··on Mask mandate and use efficacy for Covid-19 containment in US States
Per the OP:

> Higher self-reported mask use protected against SARS-CoV-1 in Beijing residents [30], but RCTs found no differences in PCR confirmed influenza among Hong Kong households assigned to hand hygiene with or without masks [mask use 31% and 49%, respectively] [31]. Medical and cloth masks did not reduce viral respiratory infections among clinicians in Vietnam [9] or China [10], and rhinovirus transmission increased among universally masked Hong Kong students and teachers in 2020 compared with prior years [32]. These findings are consistent with a 2020 CDC meta-analysis [33] and a 2020 Cochrane review update.

Care to cite the literature you're reading that contradicts these statements? I'm genuinely interested in learning more about the state of scientific consensus on this topic.

criticaltinker··on Mask mandate and use efficacy for Covid-19 containment in US States
> Our main finding is that mask mandates and use likely did not affect COVID-19 case growth. Mask mandates were associated with greater mask use but ultimately did not influence total normalized cases or post-mandate case growth.

> we did not observe lower growth rates over a range of compliance at maximum Fall-Winter growth [45-83% between South Dakota and Massachusetts during maxima] when growth rates were high. This complements a Danish RCT from 3 April to 2 June 2020, when growth rates were low, which found no association between mask use and lower COVID-19 rates either for all participants in the masked arm [47% strong compliance] or for strongly compliant participants only.

> We only assessed one biological quantity [confirmed and probable COVID-19], but the ongoing pandemic warrants assessment of other factors such as hospitalizations and mortality. Importantly, our study does not disprove the efficacy of all masks in limited and controlled circumstances, such as properly worn N95 respirators.

It's important to be aware that mandated non-pharmaceutical interventions like lock-downs, school closures, - and to a lesser degree masking - have second order effects on seasonal endemic illnesses such as influenza and RSV. Large future outbreaks of both diseases may occur following a period of extended NPIs. These outbreaks, which may reach peak numbers in the winter, could increase the burden to healthcare systems [1].

Considering these potential consequences, and the other potential negative externalities mentioned in the paper, it's imperative that such mandates be carefully scrutinized and evaluated before being widely enforced.

[1] The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections https://www.pnas.org/content/117/48/30547

criticaltinker··on Moderna contamination may impact vaccination drive [Japan]
> Over the past 10 days, foreign substances were discovered in 39 unused vials at eight vaccination sites in Japan. All the tainted vials were made in Spain and were shipped to Japan from late July.

> Japan's health ministry on Thursday decided to halt the use of about 1.63 million doses of the Moderna vaccine that were manufactured in the same factory in Spain at around the same time as the contaminated vials.

> The ministry says it has not received any reports of health damage from the vaccines.

criticaltinker··on Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity [pdf]
> The numbers in this paper are a casually spectacular defense of the vaccines

Yes the paper is certainly not an attack on vaccines. The crucial implications of the findings in OP are especially relevant to public health policy:

1) There are diminishing returns to vaccinating individuals who have already acquired immunity through natural infection. The benefits are borderline insignificant. Therefore when faced with a limited supply of vaccines, vaccination strategies should be highly focused on immunologically naive or vulnerable individuals.

2) Compulsory mass vaccination mandates need to accommodate naturally immune individuals. If they do not, such mandates are not only wasteful, but are also effectively ordering unnecessary medical procedures which is a violation of medical ethics and likely a violation of constitutional rights to bodily integrity and informed consent.

3) If vaccine effectiveness at preventing infections continues to be undermined by viral evolution, new formulations will need to be tested and deployed. The mRNA delivery mechanism supports rapid iteration in that respect, but those efforts will still take months at minimum. Consequently it will likely be necessary to supplement mass vaccination with other viral elimination strategies, such as early treatment with multi-drug therapy based on existing and widely available medicines [1][2][3][4][5].

[1] Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?a...

[2] Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.1... Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection https://rcm.imrpress.com/EN/article/downloadArticleFile.do?a...

[3] Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents https://www.sciencedirect.com/science/article/abs/pii/S03069...

[4] Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial https://pubmed.ncbi.nlm.nih.gov/33983065/

[5] Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 https://www.frontiersin.org/articles/10.3389/fphar.2021.6526...

criticaltinker··on Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity [pdf]
Yes good point, this is early work but definitely a necessary step toward answering an important question.

It's important to note the tremendous amount of evidence from a wide body of peer-reviewed literature which supports the fact that immunity acquired through natural infection provides protection against reinfection that is at least equally effective as vaccination. This fact has been repeatedly demonstrated in multiple large scale and long term serological studies [1][2][3][4][5].

- A previous history of SARS-CoV-2 infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection. This time period is the minimum probable effect because seroconversions were not included. This study shows that previous infection with SARS-CoV-2 induces effective immunity to future infections in most individuals. [1] (N=25,661)

- The study results suggest that reinfections are rare events and patients who have recovered from COVID-19 have a lower risk of reinfection. Natural immunity to SARS-CoV-2 appears to confer a protective effect for at least a year, which is similar to the protection reported in recent vaccine studies. [3] (N=15,075)

- Reinfection is rare in the young and international population of Qatar. Natural infection appears to elicit strong protection against reinfection with an efficacy ~95% for at least seven months. [4] (N=192,967)

- The degree of protection (10-fold) associated with seropositivity appears to be comparable to that observed in the initial reports of the efficacy of mRNA vaccines in large clinical trials. [5] (N=3,257,478)

The OP is one of the first and largest scale studies to evaluate the risk of reinfection - in the context of the delta variant which is currently dominant in many countries around the world - by directly comparing naturally acquired immunity to vaccine-induced immunity.

> those vaccinated are still at a 5.96-fold increased risk for breakthrough infection and at a 7.13-fold increased risk for symptomatic disease compared to those previously infected.

> SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalization compared to those who were previously infected.

If the OP study holds up to peer-review (which it likely will), then we can expect further studies attempting to replicate this finding, and even more studies attempting to explain why naturally acquired immunity induces a more robust immune response. The findings from those studies will be leveraged in the design of future vaccines - so these results will be a win just about any way you look at them.

[1] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) https://pubmed.ncbi.nlm.nih.gov/33844963/

[2] Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study https://academic.oup.com/cid/advance-article/doi/10.1093/cid...

[3] Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy https://jamanetwork.com/journals/jamainternalmedicine/fullar...

[4] SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy https://www.sciencedirect.com/science/article/pii/S258953702...

[5] Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection https://jamanetwork.com/journals/jamainternalmedicine/fullar...

criticaltinker··on Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity [pdf]
The cited study explicitly compares previously infected (not vaccinated) individuals to vaccinated individuals, so your claim is wrong.

However I will say, in a lot of the CDC literature they inconsistently refer to "unvaccinated" individuals in a manner that often does not distinguish between those with prior infection and those who are immunologically naive. I think this has been a major point of confusion for the general public who are trying to interpret the results of such studies.

criticaltinker··on Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity [pdf]
> how do you reconcile your position with [1]?

The CDC publication you cited has a relatively small sample size (N=738) and uses data from a single state during a 2-month period. The confidence interval on the "2.34" odds ratio is large (95% CI = 1.58–3.47). Most importantly, a tremendous amount of literature has contradicted their findings.

Multiple large scale and long term serological studies have demonstrated that immunity acquired through previous infection has been at least equally durable and effective as vaccination in preventing reinfection.

- A previous history of SARS-CoV-2 infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection. This time period is the minimum probable effect because seroconversions were not included. This study shows that previous infection with SARS-CoV-2 induces effective immunity to future infections in most individuals. [1] (N=25,661)

- In conclusion, documented SARS-CoV-2 reinfections were exceedingly rare, with an incidence of 0.3 infections for every 1000 persons-week, and none were severe. Seroconversion after symptomatic or asymptomatic SARS-CoV-2 infection seems to be associated with a 10-fold reduction in risk of successive viral infection contamination, lasting at least 8 months. [2] (N=1,494)

- The study results suggest that reinfections are rare events and patients who have recovered from COVID-19 have a lower risk of reinfection. Natural immunity to SARS-CoV-2 appears to confer a protective effect for at least a year, which is similar to the protection reported in recent vaccine studies. [3] (N=15,075)

- Reinfection is rare in the young and international population of Qatar. Natural infection appears to elicit strong protection against reinfection with an efficacy ~95% for at least seven months. [4] (N=192,967)

- The degree of protection (10-fold) associated with seropositivity appears to be comparable to that observed in the initial reports of the efficacy of mRNA vaccines in large clinical trials. [5] (N=3,257,478)

> One huge reason the CDC kept telling people to get vaccinated was to reduce transmission rates

It's important to note that transmission is also equally well reduced by immunity acquired through natural infection.

> It's not just about your personal health here. Yet people didn't listen, and now we have a strain whose transmission appears to be far less affected by vaccination.

You seem to be implying that if everyone had been vaccinated the virus wouldn't have mutated into a variant with increased transmission/virulence. That fact is that the current vaccines do not provide sterilizing immunity. Therefore transmission, mutation, and selective pressure would have continued at a rate that would still be extremely likely to evolve into VOCs [6]. Moreover, analogous to antibiotic resistance, evolution of vaccine resistance is a non-trivial risk associated with mass vaccination strategies [7][8]. This brings us back to OP which is strong evidence suggesting that natural infection may induce an immune response that is more robust to variants of concern such as delta.

Considering all of these facts, the optimal public health strategy will likely involve a mix of vaccination, naturally acquired immunity, and other viral elimination strategies such as early treatment using multi-drug therapies based on existing and widely available medications which have been proven to be effective at reducing hospitalization and death [9][10][11][12][13][14].

[1] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) https://pubmed.ncbi.nlm.nih.gov/33844963/

[2] Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study https://academic.oup.com/cid/advance-article/doi/10.1093/cid...

[3] Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy https://jamanetwork.com/journals/jamainternalmedicine/fullar...

[4] SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy https://www.sciencedirect.com/science/article/pii/S258953702...

[5] Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection https://jamanetwork.com/journals/jamainternalmedicine/fullar...

[6] The total number and mass of SARS-CoV-2 virions https://www.pnas.org/content/118/25/e2024815118

[7] Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein https://pubmed.ncbi.nlm.nih.gov/33909660/

[8] Can we predict the limits of SARS-CoV-2 variants and their phenotypic consequences? https://www.gov.uk/government/publications/long-term-evoluti...

[9] Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?a...

[10] Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.1...

[11] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection https://rcm.imrpress.com/EN/article/downloadArticleFile.do?a...

[12] Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents https://www.sciencedirect.com/science/article/abs/pii/S03069...

[13] Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial https://pubmed.ncbi.nlm.nih.gov/33983065/

[14] Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 https://www.frontiersin.org/articles/10.3389/fphar.2021.6526...

criticaltinker··on The Coronavirus Could Get Worse
> In the few short days most infected people need to marshal immune responses and purge the pathogen, the coronavirus has barely enough time to tweak its genome once, if at all. “The virus that comes out is going to be basically identical to the virus that goes in,” Goldstein told me. And any variants that do arise have little chance to accumulate in high enough numbers to matter.

This an egregious misrepresentation of the findings in the cited paper [1]. Here is the line the author was likely referencing:

> Therefore, if we track a single lineage of virions from the time they started replicating in the body until the end of the infection, this lineage would accumulate in the range of 0.1 to 1 mutations on average across its entire genome

The OP completely misses the forest for the trees, so to speak:

> Because the SARS-CoV-2 genome is 30,000 nucleotides long, the 105 to 108 mutations across all of the virions produced over the course of a single infection probably cover every possible single nucleotide substitution (Fig. 3A). They even cover a significant fraction of the possible pairs of single nucleotide substitutions.

> the estimated number of mutations generated daily (105 to 106 mutations per day) likely exceeds the total number of possible single nucleotide substitutions to the SARS-CoV-2 genome (≈105 substitutions) assuming 0.3 million to 3 million new cases a day worldwide. As such, our estimates imply that every single base mutation is being generated de novo and transmitted to a new SARS-CoV-2 host, somewhere in the world, every day. [1]

It's great that these articles cite sources for their claims, but keep in mind that the authors are not necessarily experts (or even remotely qualified) in the subject matter. They are liable to misinterpret and misrepresent the scientific literature they use to support their narrative.

[1] The total number and mass of SARS-CoV-2 virions https://www.pnas.org/content/118/25/e2024815118#F3

criticaltinker··on CDC: Covid vaccine effectiveness fell from 91% to 66% with Delta variant
So I say "The threat of vaccine resistance is real and acknowledged by many experts" and provide citations to support this claim - then you reply:

> This isn't a point against the vaccine [...] and doesn't support the anti vax argument

You're attacking a straw man with an overly simplistic reductionist interpretation. I'm not "against the vaccine", but clearly your bias here is to defend vaccination and disregard any nuanced criticisms from experts at top institutions as "anti-vax".

I won't continue to discuss this with you because it's obvious you don't intend to cultivate an informed discussion.

criticaltinker··on CDC: Covid vaccine effectiveness fell from 91% to 66% with Delta variant
> he is just an antivaxxer spreading unscientific lies

No need for ad hominem rebuttals here.

The threat of vaccine resistance is real and acknowledged by many experts [1][2], but I agree he is not doing these ideas justice by making such simple and unbalanced comments without citing any primary sources.

[1] Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein https://pubmed.ncbi.nlm.nih.gov/33909660/

[2] Can we predict the limits of SARS-CoV-2 variants and their phenotypic consequences? https://www.gov.uk/government/publications/long-term-evoluti...

criticaltinker··on CDC: Covid vaccine effectiveness fell from 91% to 66% with Delta variant
> Every healthy responsible person gets a flu shot every single fall

The implication of your phrasing here is that people who do not get a flu shot every single fall are irresponsible - which seems pretty silly to claim given that seasonal influenza does not pose a significant risk to a majority of the population, especially healthy children and adults.

criticaltinker··on CDC: Covid vaccine effectiveness fell from 91% to 66% with Delta variant
I'm with you on your general point - however you made some strong claims which are not supported by any literature I've seen (and I read a lot of literature on the topic, but of course I haven't read it all).

> Natural immunity is much better than the vaccines

The literature supports the fact that immunity acquired through natural infection is at least as effective as vaccination. I'm not aware of any strong evidence that one is better than the other in terms of individual health outcomes. It has been established that natural infection induces an immune response that includes nucleocapsid protein antibodies whereas vaccination with the current mRNA formulations does not. There are other subtle differences in the immune response, and those may have a significant long-term impact on both individual health outcomes and viral evolution at a population level, but scientific evidence on those points is extremely limited.

> The rate of severe infection with Delta among vaccinated is higher than the rate of severe infection of the general population a year ago with Original COVID

> Natural immunity has less than 1% reinfection rate vs a nearly 40% infection rate for fully vaccinated

I'm all for challenging the status quo but folks really need to start citing primary sources to support such claims, otherwise they will be dismissed as uninformed opinion.

criticaltinker··on What Happens When You Take 550 Doses of LSD at Once
Very interesting stories - such massive doses of psychedelics can be dangerous for a number of reasons and you really shouldn't ingest anywhere near such dosages without medical care on standby.

In general though, anecdotes of psychedelics curing a number of mental illnesses are starting to become well supported by the scientific literature. The wide variety of benefits from psychedelics - particularly psilocybin - are being actively investigated in quite a few clinical trials. We're talking about safe and long-term cures for depression, anxiety, addiction - while also promoting neurogenesis and neuroplasticity [1][2][3].

I believe we're on the brink of a modern psychedelic revolution in medicine, one that has been long overdue since these effects were documented and investigated over 70 years ago - and known to ancient indigenous cultures for thousands of years.

[1] Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years https://journals.sagepub.com/doi/pdf/10.1177/204512531663800...

[2] Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning http://www.psilosophy.info/resources/Effects%20of%20psilocyb...

[3] Psychedelics as a Treatment for Alzheimer’s Disease Dementia https://www.frontiersin.org/articles/10.3389/fnsyn.2020.0003...

criticaltinker··on CDC: Covid vaccine effectiveness fell from 91% to 66% with Delta variant
Immunity acquired through natural infection confers protection that is at least as effective as vaccination [1]. However, the delta variant and other VOCs have mutations that will reduce this protection in both vaccinated and naturally immune individuals.

> A previous history of SARS-CoV-2 infection was associated with an 84% lower risk of infection, with median protective effect observed 7 months following primary infection. This time period is the minimum probable effect because seroconversions were not included. This study shows that previous infection with SARS-CoV-2 induces effective immunity to future infections in most individuals. [1]

[1] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) https://pubmed.ncbi.nlm.nih.gov/33844963/

criticaltinker··on ‘What do you think you’re doing?’: Sydneysiders stung for eating outside
Despite the strict lock-downs, the rate of confirmed new cases has been skyrocketing for the past week in NZ [1] (and many other countries), with no clear end in sight.

Only ~20% of the NZ population has been fully vaccinated [2].

> In the next week our lockdown will be over and we’ll have no cases

> Completely 100% normal prepandemic life all for the easy price of a momentary blip of inconvenience

I honestly can't tell if your comment is satire or propaganda. Assuming you've commented in good faith - why do you believe there will be no cases next week? Don't you think it's likely that the prime minister extends the lock-down orders, again?

[1] https://ourworldindata.org/coronavirus/country/new-zealand#d...

[2] https://ourworldindata.org/coronavirus/country/new-zealand#w...

criticaltinker··on HN Idea
Interesting idea but there's a lot of edge cases to think through. Maybe this could be implemented with a custom front-end that interacts with the HN API?

HN is still working on rolling out some basic usability features such as pagination. Not to shoot down your idea, but realistically stuff like this won't make it into HN for a long time. And that might be a good thing - HN prides itself on relatively simple UX and fairly straightforward rules for ranking articles and comments (even though behind the scenes there is more sophistication, e.g. voting ring detection, etc).

criticaltinker··on Ask HN: I love coding, but I hate web development. How can I “jump ship”?
What motivates you the most - money or alignment with your natural interests? Look around the job market and pick a position to focus on that strikes a reasonable balance between the two.

Embedded systems engineers command great salaries, so do full stack engineers. I wouldn't recommend game development if you want to continue enjoying it as a hobby, the industry notoriously burns people out quickly.

Once you've decided on a position to focus on, search through a bunch of job postings and take notes on the skills and technologies that employers are looking for. Study those skills and technologies by reading books and working on toy problems that interest you. Putting together an open source project is a great way to demonstrate these skills to potential employers, but definitely not necessary. Be on the look-out for jobs and employers that seem particularly interesting to you.

When you feel reasonably in touch with the basics and fundamentals, start applying for positions. Start out with employers and positions that you don't particularly care for, use the interviews to practice your rhetoric and build your confidence.

Make sure to have trusted friends/coworkers/mentors in the field review your resume and give you feedback. I avoid listing any particular technologies on my resume, because sometimes they can box you in - but admittedly some employers will be looking for X Y & Z technology listed on your resume, so don't be afraid to make small tweaks for specific companies and positions you are really interested in. Don't be afraid to embellish your resume and work history - it's okay to say you led a team even if that responsibility was never formally acknowledged. Don't outright lie though, and be very prepared for interviewers to ask in depth questions about your prior experience - I usually bring a notepad with talking points to help me remember all the details of projects I've worked on. Don't be afraid to admit a lack of professional experience with some technology - having experience with such technology on personal projects can go a long way towards demonstrating aptitude.

Finally apply to those jobs and employers that stuck out to you - the ones you really wanted or were interested in learning more about. Try to give off a vibe of ambition and hunger to achieve, managers will pick up on those traits, whether consciously or subconsciously. Technologies come and go but soft skills are very important so feel free to mention that you're a great technical writer or that you are an excellent mediator of conflict, etc - it can help fill the gaps of experience or knowledge in a domain.

Most of all believe in yourself and your capacity to learn and grow - that will be the primary factor in your success.

criticaltinker··on Scylla – Real-Time Big Data Database
The benchmarks against DynamoDB, Bigtable, & CockroachDB [1] appear quite impressive - anyone have real world experience that can attest to these claims of improved performance and reduced cost?

> Scylla vs DynamoDB – Database Benchmark

> 20x better throughput in the hot-partition test

> Scylla Cloud is 1/7 the expense of DynamoDB when running equivalent workloads

> Scylla Cloud: Average replication latency of 82ms. DynamoDB: Average latency of 370ms.

> Scylla vs Bigtable – Database Benchmark

> Scylla Cloud performs 26X better than Google Cloud Bigtable when applied with real-world, unoptimized data distribution

> Google BigTable requires 10X as many nodes to accept the same workload as Scylla Cloud

> Scylla Cloud was able to sustain 26x the throughput, and with read latencies 1/800th and write latencies less than 1/100th of Cloud Bigtable

> Scylla vs CockroachDB – Database Benchmark

> Loading 10x the data into Scylla took less than half the time it took for CockroachDB to load the much lesser dataset.

> Scylla handled 10x the amount of data.

> Scylla achieved 9.3x the throughput of CockroachDB at 1/4th the latency.

[1] https://www.scylladb.com/product/benchmarks/

criticaltinker··on CIA report into shoring up Afghan war support in Western Europe, 11 Mar 2010
Summary:

> This classified CIA analysis from March outlines possible PR strategies to shore up public support in Germany and France for a continued war in Afghanistan.

> The proposed PR strategies focus on pressure points that have been identified within these countries.

> For France it is the sympathy of the public for Afghan refugees and women.

> For Germany it is the fear of the consequences of defeat (drugs, more refugees, terrorism) as well as for Germany's standing in NATO.

> The memo is a recipe for the targeted manipulation of public opinion in two NATO ally countries, written by the CIA. It is classified as Confidential/No Foreign Nationals.

criticaltinker··on Delta variant will acquire complete resistance to wild-type spike vaccines
> Delta remains handled by current mRNA

Depends what you mean by "handled". Per the CDC [1]:

> [vaccine efficiency at preventing infection] declined from 91% before predominance of the SARS-CoV-2 Delta variant to 66% since the SARS-CoV-2 Delta variant became predominant

Per OP:

> Because the Delta variant is spreading so explosively, it has already acquired numerous additional mutations in the spike protein coding region, suggesting that the Delta variant will continue to acquire further mutations.

> A third round of booster immunization with the SARS-CoV-2 vaccine is currently under consideration. Our data suggest that repeated immunization with the wild-type spike may not be effective in controlling the newly emerging Delta variants.

[1] Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021 https://www.cdc.gov/mmwr/volumes/70/wr/mm7034e4.htm

criticaltinker··on Ask HN: Have you ever written code that you later regretted for ethical reasons?
Is it unethical to leave behind horrendously complex and undocumented code for your coworkers to inherit? Then I'd say yes - many of us have been on one or both sides of that situation, and regretted it.
criticaltinker··on Delta variant will acquire complete resistance to wild-type spike vaccines
Some highlights from my notes on the OP [1]:

> All anti-NTD neutralizing antibodies failed to recognize the Delta spike, indicating that the Delta variant is completely resistant to anti-NTD neutralizing antibodies elicited by wild-type spike protein, which is the antigenic component of widely used mRNA vaccines.

> A third round of booster immunization with the SARS-CoV-2 vaccine is currently under consideration. Our data suggest that repeated immunization with the wild-type spike may not be effective in controlling the newly emerging Delta variants.

[1] The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1

criticaltinker··on Covid-19: Children born during the pandemic score lower on cognitive tests
I agree it's pretty sad but all hope isn't lost - kids are notorious for their neuroplasticity in early years, it's possible that with proper care this generation will catch up to their peers and not suffer any major consequences through their adult life.
criticaltinker··on Programmers Don’t Understand Hash Functions
Pretty much synonymous with "cryptographic hash functions" [1], just referring to a specific use-case.

> derive one or more keys from a common secret value (which is sometimes also referred to as "key diversification").

> Such use may prevent an attacker who obtains a derived key from learning useful information about either the input secret value or any of the other derived keys

[1] https://en.wikipedia.org/wiki/Key_derivation_function

criticaltinker··on Covid-19: Children born during the pandemic score lower on cognitive tests
These findings may reflect the second and third order consequences of mandatory non-pharmaceutical interventions such as lock-downs, masking, & school/daycare/work closures - which are likely to have a greater impact on poor or uneducated families who lack the resources to effectively compensate for such changes.

Highlights from OP and the cited paper (interesting limitation at the end):

> In a longitudinal study of 672 children from Rhode Island that has run since 2011, those born after the pandemic began showed results on the Mullen scales of early learning that corresponded to an average IQ score of 78, a drop of 22 points from the average of previous cohorts.

> We find that children born during the pandemic have significantly reduced verbal, motor, and overall cognitive performance compared to children born pre-pandemic. [1]

> In terms of effect size, lead author of the longitudinal study and paediatrician Sean Deoni said, “the closest thing we’ve seen in other research — and this is horrible, not a good comparison to be making — is the studies that were done of orphans in Romania. The effects of institutionalisation and lack of interaction on them were profound, but what we’re seeing here is on par with that.”

> we find that males and children in lower socioeconomic families have been most affected [1]

> “we do have some preliminary data that we’re working on in a separate study using miniature recorders which the infants wear on their chest which measure the interaction between the caregiver and the child, and what we are seeing, anecdotally, is a significant depression in the number of words spoken to kids and, as you can imagine, a massive increase in TV exposure, and a decline in meaningful conversations. Time spent engaged with a caregiver is way down.”

> Results highlight that even in the absence of direct SARS-CoV-2 infection and COVID-19 illness, the environmental changes associated COVID-19 pandemic is significantly and negatively affecting infant and child development.

> One aspect also not investigated here is the impact of mask-wearing by the study staff during child visits and assessments. The inability of infants to see full facial expressions may have eliminated non-verbal cues, muffled instructions, or otherwise altered the understanding of the test questions and instructions.

[1] Impact of the COVID-19 Pandemic on Early Child Cognitive Development: Initial Findings in a Longitudinal Observational Study of Child Health https://www.medrxiv.org/content/medrxiv/early/2021/08/11/202...

criticaltinker··on Programmers Don’t Understand Hash Functions
The spectrum of hash functions can be outlined in a fairly straightforward manner:

A) Perceptual (fast, similar inputs result in similar hashes - by design)

B) Checksum (fast, hash collisions from different inputs should be expected - by chance)

C) Cryptographic (slow, similar inputs results in very different hashes - by design)

Many security vulnerabilities involving hash functions come from using A or B when C should have been used. More subtle vulnerabilities come from not using a cryptographically strong algorithm for C (eg SHA1, and more recently SHA2), or not appending a unique and random "salt" to every input of C - so when your database is compromised attackers can pre-compute hashes for common passwords (if the attacker also has access to the secret key supplied to the hash function).

As the OP notes, these are fairly well known hazards which are easy to find more information on. I enjoyed reading about the more nuanced scenarios brought up by OP since they aren't as commonly discussed.

criticaltinker··on First U.S. Covid deaths came earlier than previously thought
> COVID was doubling roughly every 5 days

Can you provide any citation or reference on this claim? 5 days sounds about right to me, but I'm not yet aware of any literature supporting that number so I would be grateful to learn more.

criticaltinker··on New Zealand Covid-19 Delta outbreak spreading rapidly as cases jump
> Prime Minister Jacinda Ardern extended the strict level 4 national lockdown to Aug. 27

> Australian Prime Minister Scott Morrison said elimination cannot be pursued forever [...] The way through is to get to those 70% and 80% (vaccination) marks, open safely

~34% of the population in New Zealand has received at least one vaccine dose [1], ~20% is fully vaccinated [2]. The rate of new cases jumped slightly at the same time last year [3].

New Zealand would definitely benefit from an increased vaccination rate, and strict non-pharmaceutical interventions (NPIs) are undoubtedly helping slow the spread of the virus while preventing hospitals from being overwhelmed.

However, such strict NPI policies are also preventing a significant portion of the population - people who are healthy and would likely be asymptomatic - from acquiring immunity through natural infection [12][13]. Paradoxically, this phenomenon may be prolonging and worsening the situation, because a significant portion of people will lack effective immunity against variants. Consequently, infections and cases may spike rapidly and uncontrollably, especially with variants demonstrating increasing transmissibility like delta. Moreover, strict NPIs are likely to create very bad winters in terms of endemic illnesses such as influenza and RSV, threatening to put even more strain on limited healthcare resources [11].

So while vaccination is definitely part of the solution here, it can also be complemented with other strategies such as early treatment using a multi-drug regime [4][5][6][7][8][9][10]. People who are particularly vulnerable - ie elderly with co-morbidities - should certainly quarantine until they've been fully vaccinated, but the tradeoffs involved in keeping everyone else locked down are not quite as obvious or simple to reason about.

[1] https://ourworldindata.org/coronavirus/country/new-zealand#w...

[2] https://ourworldindata.org/coronavirus/country/new-zealand#w...

[3] https://ourworldindata.org/coronavirus/country/new-zealand#w...

[4] Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?a...

[5] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection https://rcm.imrpress.com/EN/article/downloadArticleFile.do?a...

[6] Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents https://www.sciencedirect.com/science/article/abs/pii/S03069...

[7] Multidrug treatment for COVID-19 https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_202...

[8] Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial https://pubmed.ncbi.nlm.nih.gov/33983065/

[9] Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 https://www.frontiersin.org/articles/10.3389/fphar.2021.6526...

[10] Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 https://pubmed.ncbi.nlm.nih.gov/33306283/

[11] The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections https://www.pnas.org/content/117/48/30547

[12] Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells https://www.cell.com/cell-reports-medicine/fulltext/S2666-37...

[13] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) https://pubmed.ncbi.nlm.nih.gov/33844963/

← PreviousPage 6 of 15Next →